Dividend Information About Lifevantage: Everything You Need To Know Before Its Ex-Dividend Date on Sep 8, 2025
Generado por agente de IAAinvest Dividend Digest
jueves, 4 de septiembre de 2025, 7:16 pm ET1 min de lectura
LFVN--
Lifevantage (LFVN) recently announced its upcoming dividend distribution for shareholders, with the ex-dividend date set for Sep 8, 2025. Investors must hold shares before this date to qualify for the cash dividend of $0.04500000 per share, which will be paid on Sep 16, 2025. The announcement was made on Aug 28, 2025, marking the official start of the dividend cycle for this quarter. Looking at the average of the last 10 dividend payments, the current payout of $0.04500000 is lower than the average of $0.06178****285714284, indicating a potential adjustment in the company’s dividend strategy. This is consistent with the last dividend payout on Jun 13, 2025, where the same cash dividend amount of $0.04500000 was issued, suggesting a continuation of this adjusted level for the recent payout.
Over the past week, LifevantageLFVN-- has seen several key developments influencing its market performance and fundamentals. The company recently announced its financial results for the fourth fiscal quarter and full fiscal year 2025, reporting revenue of $228.5 million, reflecting a 14.2% year-over-year increase. This growth was driven by strong international expansion and margin improvements. In addition, Lifevantage completed the strategic acquisition of LoveBiome, a move that expanded its network of consultants and strengthened its position in the rapidly growing gut health market. The acquisition is expected to play a crucial role in differentiating the company’s offerings and accelerating its growth trajectory.
Since the last update, Lifevantage also outlined its revenue target for fiscal year 2026, projecting a range of $225 million to $240 million. This forward-looking guidance reflects the company’s confidence in its business strategy and recent operational improvements. While the fourth-quarter earnings exceeded estimates at $0.17 per share, revenue fell short of forecasts, leading to a sharp decline in the stock price in after-hours trading. Despite the mixed quarterly results, the company’s recent actions—including the acquisition and improved financial metrics—suggest a solid foundation for future growth.
In summary, Lifevantage appears to be navigating a period of strategic expansion and financial stabilization. The recent acquisition of LoveBiome, combined with improved international momentum and margin efficiency, signals a focused approach to long-term value creation. As investors prepare for the upcoming dividend on Sep 16, 2025, it is important to note that the ex-dividend date is Sep 8, 2025, which is the last day for investors to purchase shares and still be eligible for the dividend. Any purchase after this date will not qualify for the distribution.
Over the past week, LifevantageLFVN-- has seen several key developments influencing its market performance and fundamentals. The company recently announced its financial results for the fourth fiscal quarter and full fiscal year 2025, reporting revenue of $228.5 million, reflecting a 14.2% year-over-year increase. This growth was driven by strong international expansion and margin improvements. In addition, Lifevantage completed the strategic acquisition of LoveBiome, a move that expanded its network of consultants and strengthened its position in the rapidly growing gut health market. The acquisition is expected to play a crucial role in differentiating the company’s offerings and accelerating its growth trajectory.
Since the last update, Lifevantage also outlined its revenue target for fiscal year 2026, projecting a range of $225 million to $240 million. This forward-looking guidance reflects the company’s confidence in its business strategy and recent operational improvements. While the fourth-quarter earnings exceeded estimates at $0.17 per share, revenue fell short of forecasts, leading to a sharp decline in the stock price in after-hours trading. Despite the mixed quarterly results, the company’s recent actions—including the acquisition and improved financial metrics—suggest a solid foundation for future growth.
In summary, Lifevantage appears to be navigating a period of strategic expansion and financial stabilization. The recent acquisition of LoveBiome, combined with improved international momentum and margin efficiency, signals a focused approach to long-term value creation. As investors prepare for the upcoming dividend on Sep 16, 2025, it is important to note that the ex-dividend date is Sep 8, 2025, which is the last day for investors to purchase shares and still be eligible for the dividend. Any purchase after this date will not qualify for the distribution.

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios